HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by NorthRock Partners LLC

NorthRock Partners LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 205.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,002 shares of the company's stock after buying an additional 1,347 shares during the quarter. NorthRock Partners LLC's holdings in HCA Healthcare were worth $601,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Barclays PLC boosted its position in shares of HCA Healthcare by 22.3% during the 3rd quarter. Barclays PLC now owns 571,975 shares of the company's stock valued at $232,467,000 after acquiring an additional 104,409 shares during the last quarter. Miracle Mile Advisors LLC purchased a new position in shares of HCA Healthcare in the fourth quarter valued at $385,000. Marcum Wealth LLC increased its holdings in shares of HCA Healthcare by 14.6% in the 4th quarter. Marcum Wealth LLC now owns 706 shares of the company's stock worth $212,000 after buying an additional 90 shares during the last quarter. Fifth Third Wealth Advisors LLC bought a new stake in shares of HCA Healthcare in the 4th quarter worth about $268,000. Finally, Park Avenue Securities LLC increased its holdings in shares of HCA Healthcare by 6.0% in the 4th quarter. Park Avenue Securities LLC now owns 12,707 shares of the company's stock worth $3,814,000 after buying an additional 719 shares during the last quarter. Institutional investors own 62.73% of the company's stock.

Analyst Ratings Changes

A number of research firms recently commented on HCA. Robert W. Baird reaffirmed a "neutral" rating and set a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. StockNews.com raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Monday, April 28th. Royal Bank of Canada lowered their price objective on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Bank of America lowered their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research report on Monday, January 27th. Finally, Baird R W cut shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. One analyst has rated the stock with a sell rating, six have given a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $381.13.

Insiders Place Their Bets

In related news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer now directly owns 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 1.30% of the company's stock.

HCA Healthcare Stock Down 0.2%

NYSE:HCA traded down $0.78 during midday trading on Monday, reaching $386.74. 2,041,073 shares of the stock traded hands, compared to its average volume of 1,432,465. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The stock has a market capitalization of $93.04 billion, a PE ratio of 17.60, a price-to-earnings-growth ratio of 1.10 and a beta of 1.46. The business has a 50-day moving average of $340.72 and a two-hundred day moving average of $328.30.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The business had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. HCA Healthcare's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $5.36 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.74%. The ex-dividend date is Monday, June 16th. HCA Healthcare's dividend payout ratio is currently 12.81%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.